Beta Bionics, Inc. BBNX recently announced a partnership with Senseonics SENS to expand compatibility between its automated ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced a partnership to integrate the iLet Bionic Pancreas and mint ...

Ekso Bionics is set to be sold after a recent reverse merger turned the formerly Marin County-based exoskeleton company into an artificial-intelligence-focused public firm.

Beta Bionics (BBNX) reported Tuesday a partnership to integrate its iLet Bionic Pancreas and mint automated insulin delivery systems with Senseonics' (SENS) Eversense 365 continuous glucose monitoring ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its third quarter 2026 financial results ...

Ekso Bionics reports record Q4-2024 revenue of $5.1 million with improved gross margins and strategic distributor partnership. Ekso Bionics Holdings, Inc., a leader in exoskeleton technology, reported ...

Mint patch pump 2027 launch, $150M raise, lowered sales guidance and margin dilution risks. Click to read my analysis.